- Corporate Officers - T
- Thomas Paul
Insider Trading History of Thomas Paul
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Thomas Paul since 2006.
This trader's CIK number is 1166776.
At the time of last reporting, Thomas Paul was the Officer of Axogen, Inc.. (stock ticker symbol AXGN).
Also see all insider trading activities at Axogen, Inc..
Note that in the past
THOMAS PAUL also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Abiomed Inc (ABMD) by Thomas Paul
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2021 | ABMD | 0 | $0 | 663 | $219,300 | 0 | $0 |
| 2020 | ABMD | 0 | $0 | 6,000 | $1,272,632 | 0 | $0 |
| 2017 | ABMD | 0 | $0 | 10,000 | $1,547,080 | 0 | $0 |
| 2016 | ABMD | 0 | $0 | 17,500 | $1,902,365 | 17,500 | $248,800 |
| 2015 | ABMD | 0 | $0 | 7,500 | $704,332 | 7,500 | $59,400 |
Yearly summary of insider trading at Axogen, Inc. (AXGN) by Thomas Paul
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2023 | AXGN | 0 | $0 | 0 | $0 | 6,459 | $0 |
Yearly summary of insider trading at Lifecell Corp (LIFC) by Thomas Paul
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2008 | LIFC | 0 | $0 | 133,528 | $5,782,761 | 19,276 | $274,355 |
| 2007 | LIFC | 0 | $0 | 67,060 | $2,877,405 | 72,254 | $613,891 |
| 2006 | LIFC | 0 | $0 | 0 | $0 | 237,712 | $710,963 |
Insider trading activities at 3 companies by Thomas Paul:
1. Abiomed Inc (ABMD)
2. Axogen, Inc. (AXGN)
3. Lifecell Corp (LIFC)
Table 1. Insider trading of Abiomed Inc (ABMD) by Thomas Paul
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2021-08-18 | ABMD | Sale | 663 | 330.77 | 219,300 |
| 2020-08-10 | ABMD | Sale | 2,000 | 303.41 | 606,820 |
| 2020-03-02 | ABMD | Sale | 2,000 | 151.78 | 303,562 |
| 2020-02-10 | ABMD | Sale | 2,000 | 181.12 | 362,250 |
| 2017-08-15 | ABMD | Sale | 10,000 | 154.71 | 1,547,080 |
| 2016-08-01 | ABMD | Sale | 10,000 | 118.66 | 1,186,550 |
| 2016-08-01 | ABMD | Option Ex | 10,000 | 18.94 | 189,400 |
| 2016-05-05 | ABMD | Option Ex | 7,500 | 7.92 | 59,400 |
| 2016-05-05 | ABMD | Sale | 7,500 | 95.44 | 715,815 |
| 2015-08-06 | ABMD | Sale | 7,500 | 93.91 | 704,332 |
| 2015-08-06 | ABMD | Option Ex | 7,500 | 7.92 | 59,400 |
Table 2. Insider trading of Axogen, Inc. (AXGN) by Thomas Paul
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2023-06-01 | AXGN | Option Ex | 6,459 | .00 | 0 |
Table 3. Insider trading of Lifecell Corp (LIFC) by Thomas Paul
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2008-01-04 | LIFC | Sale | 68,276 | 43.26 | 2,953,414 |
| 2008-01-03 | LIFC | Option Ex | 19,276 | 14.23 | 274,355 |
| 2008-01-03 | LIFC | Sale | 19,734 | 44.00 | 868,296 |
| 2008-01-02 | LIFC | Sale | 45,518 | 43.08 | 1,961,051 |
| 2007-12-12 | LIFC | Option Ex | 25,000 | 5.27 | 131,750 |
| 2007-12-12 | LIFC | Sale | 25,000 | 46.24 | 1,156,100 |
| 2007-12-03 | LIFC | Sale | 42,060 | 40.92 | 1,721,305 |
| 2007-12-03 | LIFC | Option Ex | 42,060 | 9.09 | 382,157 |
| 2007-10-04 | LIFC | Option Ex | 5,194 | 19.25 | 99,984 |
| 2006-12-27 | LIFC | Option Ex | 36,496 | 2.74 | 99,999 |
| 2006-04-03 | LIFC | Option Ex | 14,720 | 2.26 | 33,267 |
| 2006-03-21 | LIFC | Option Ex | 36,496 | 2.74 | 99,999 |
| 2006-03-01 | LIFC | Option Ex | 40,000 | 3.77 | 150,600 |
| 2006-03-02 | LIFC | Option Ex | 10,000 | 2.26 | 22,599 |
| 2006-02-01 | LIFC | Option Ex | 30,000 | 2.74 | 82,200 |
| 2006-02-02 | LIFC | Option Ex | 5,900 | 2.74 | 16,166 |
| 2006-02-03 | LIFC | Option Ex | 14,100 | 4.00 | 56,470 |
| 2006-01-09 | LIFC | Option Ex | 33,500 | 3.12 | 104,453 |
| 2006-01-11 | LIFC | Option Ex | 16,500 | 2.74 | 45,210 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Thomas Paul
(Officer of Axogen, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.